Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma

Danielle M. Tholey, Joseph Ahn

Research output: Contribution to journalReview article

16 Scopus citations

Abstract

Hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) incidence in the United States is increasing, partly because of risk factors such as diabetes, fatty liver, hepatitis B virus, and human immunodeficiency virus coinfection. Achieving sustained virologic response (SVR) is the most significant factor in reducing HCV-associated HCC incidence. Improved SVR with the next generation of direct-acting antivirals brings hope for decreased HCC mortality. Nevertheless, surveillance for HCC remains important because HCC can still occur despite SVR, especially in cirrhotics. Individualized risk stratification through increased understanding of HCC pathogenesis and improved surveillance holds the promise for future reduction of HCC incidence.

Original languageEnglish (US)
Pages (from-to)761-773
Number of pages13
JournalGastroenterology Clinics of North America
Volume44
Issue number4
DOIs
StatePublished - Dec 2015

Keywords

  • Direct-acting antivirals
  • Hepatitis C virus
  • Hepatocellular carcinoma
  • Liver cancer

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma'. Together they form a unique fingerprint.

  • Cite this